KAUST and Research Products Development Company (RPDC) have signed a partnership agreement to support technology commercialization and early-stage startups in Saudi Arabia. RPDC and the KAUST Innovation Fund will co-invest in startups and establish a joint mentorship and startup exchange program. RPDC will co-invest or match KAUST funding of up to $2 million into deep tech startups at the proof-of-concept, seed and series A funding stages. Why it matters: This collaboration aims to bolster the innovation ecosystem within Saudi Arabia, accelerating the transition of academic research to commercial applications.
The Research Products Development Company (RPDC) signed an agreement with The Saudi Vaccine and Biomanufacturing Center (SVBC) to establish a research and industrial center in Saudi Arabia for vaccine and biopharmaceutical development. Supported by KACST and hosted by KAUST, the SVBC will provide a state-of-the-art facility and a training platform. Cooperation agreements were also signed with GE for equipment supply and with Fujifilm Dayosent Biotechnology for MERS-CoV treatment development. Why it matters: This initiative aims to localize vaccine and advanced treatment industries in Saudi Arabia, create technical jobs, and reduce reliance on imports in line with Vision 2030.
Red Sea Farms, a KAUST spinout specializing in saltwater greenhouse technology, secured $1.9 million in co-investment from the KAUST Innovation Fund and Research Products Development Company (RPDC). Their system uses saltwater to grow crops, reducing freshwater and energy requirements up to tenfold. The investment will enable the company to build a 2,000 square meter saltwater greenhouse on the KAUST campus, with a goal of producing 50 tons of tomatoes annually by 2020. Why it matters: This investment supports sustainable agriculture innovation in the water-scarce Middle East, offering a model for reducing the environmental impact of food production.